Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation

BACKGROUND: Cystic fibrosis lung disease is characterized by chronic bacterial infections in the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest with increased respiratory symptoms that require intensification of therapy with enhanced airway clearance and int...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhlebach, Marianne S., Sha, Wei, MacIntosh, Beth, Kelley, Thomas J., Muenzer, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424819/
https://www.ncbi.nlm.nih.gov/pubmed/32812947
http://dx.doi.org/10.1016/j.metop.2019.100010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424819/
https://www.ncbi.nlm.nih.gov/pubmed/32812947
http://dx.doi.org/10.1016/j.metop.2019.100010

Ejemplares similares